Small Animal Imaging (In-vivo) Market Size & Growth Forecast 2027–2036, By Segments (Modality, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Small Animal Imaging (In-vivo) Market size was estimated at USD 1.4 billion in 2026 and is projected to grow at a 7.41% CAGR from 2027 to 2036, exceeding USD 2.86 billion by 2036. The industry revenue for 2027 is assessed at USD 1.49 billion.
Get more details on this report
Request Free Sample ReportSmall Animal Imaging (In-vivo) Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 38.05% market share in 2026, supported by advanced preclinical research infrastructure, strong translational research investment, and widespread imaging adoption across research institutions.
- Asia Pacific is forecast to grow at an 8.7% CAGR as biomedical research expands and more universities, CROs, and pharmaceutical programs adopt in-vivo imaging platforms.
Segment Momentum
- Optical Imaging Systems captured 40.81% of the market in 2026 because they support efficient, repeatable longitudinal imaging across diverse preclinical research workflows, making them a routine choice for laboratory operations.
- Cell Detection is growing rapidly as researchers increasingly require precise monitoring of cell localization, migration, and persistence, aligning with greater demand for mechanism-focused preclinical studies and cellular tracking.
Market Expansion Drivers
- Growing preclinical drug development increasing demand for in-vivo animal imaging studies.
- Advancements in high-resolution imaging modalities enhancing research accuracy and speed.
- Rising pharmaceutical R&D investments and regulatory approvals accelerating preclinical imaging adoption.
Leading Market Participants
- Leading players in the small animal imaging (in-vivo) market include PerkinElmer, Inc. (United States), Bruker Corporation (United States), Siemens Healthineers AG (Germany), FUJIFILM Holdings Corporation (Japan), Thermo Fisher Scientific Inc. (United States), Miltenyi Biotec B.V. & Co. KG (Germany), Aspect Imaging Ltd. (Israel), Mediso Ltd. (Hungary), Promega Corporation (United States), Revvity, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.4 billion
- 2027 Estimated Market Size: USD 1.49 billion.
- Projected Market Size: USD 2.86 billion by 2036
- Growth Forecast: 7.41% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Optical Imaging Systems (Modality) | Biodistribution Studies (Application)
- Emerging Opportunity Segment: Micro-magnetic Resonance Imaging (Modality) | Cell Detection (Application)
Market Growth Drivers and Industry Trends
Growing preclinical drug development increasing demand for in-vivo animal imaging studies
Growing preclinical drug development will drive the small animal imaging (in-vivo) market as researchers require imaging studies to evaluate biological responses and disease progression during drug research. In-vivo imaging enables observations within living subjects, supporting research workflows that require assessment of treatment effects throughout preclinical development.
Advancements in high-resolution imaging modalities enhancing research accuracy and speed
Advancements in high-resolution imaging modalities will propel the small animal imaging (in-vivo) market by improving the ability of researchers to capture detailed biological information during studies. Greater imaging resolution can support more precise observations while helping research teams conduct evaluations with improved efficiency across preclinical investigations.
Rising pharmaceutical R&D investments and regulatory approvals accelerating preclinical imaging adoption
Rising pharmaceutical R&D investments will strengthen the small animal imaging (in-vivo) market as increased research activity creates greater requirements for preclinical imaging capabilities. Regulatory approvals can further support adoption by enabling development programs to progress through research stages where imaging is used to assess biological responses and treatment performance.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing preclinical drug development increasing demand for in-vivo animal imaging studies | 2.30% | High | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in high-resolution imaging modalities enhancing research accuracy and speed | 2.00% | Moderate | North America, Europe | High | Mid Term |
| Rising pharmaceutical R&D investments and regulatory approvals accelerating preclinical imaging adoption | 1.60% | High | North America, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the small animal imaging (in-vivo) market with a 38.05% share in 2026, supported by extensive biomedical research activity, advanced preclinical testing infrastructure, and strong adoption of sophisticated imaging technologies. The region has a well-developed ecosystem for pharmaceutical and biotechnology research, creating sustained demand for noninvasive imaging tools used to study disease progression, drug efficacy, and biological processes in living subjects. Increasing emphasis on translational research is also encouraging the use of imaging modalities that enable researchers to monitor therapeutic responses over time. Strong investment in laboratory infrastructure, veterinary research, and precision-focused preclinical studies further supports the region's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, driven by expanding pharmaceutical and biotechnology research, increasing investment in life sciences infrastructure, and rising demand for advanced preclinical research capabilities. Growing research activity in areas such as oncology, neurological disorders, and regenerative medicine is encouraging wider use of in-vivo imaging to improve experimental evaluation and accelerate therapeutic development. Improvements in laboratory facilities and greater adoption of advanced imaging systems are also broadening access to sophisticated preclinical technologies. The region's expanding scientific workforce and increasing emphasis on domestic biomedical innovation provide additional momentum for market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Imaging InnovationGermany emphasizes advanced in-vivo imaging technologies for biomedical research and drug development programs. Research organizations increasingly integrate high-resolution imaging systems to strengthen disease modeling and experimental reproducibility.
France 🇫🇷
Academic Research IntegrationFrance strengthens adoption of in-vivo imaging systems through collaborative research centers and biomedical institutes. French laboratories prioritize imaging solutions that support multidisciplinary studies and efficient preclinical data generation.
Italy 🇮🇹
Clinical Research ConnectivityItaly applies small animal imaging technologies within university research and pharmaceutical development programs. Demand reflects the need for reliable imaging platforms that enhance preclinical research quality and facilitate collaboration across scientific institutions.
Japan 🇯🇵
Preclinical Imaging ExcellenceJapan prioritizes sophisticated in-vivo imaging platforms supporting regenerative medicine, oncology, and neuroscience research. Laboratories value compact, high-sensitivity systems that deliver consistent imaging performance for complex preclinical investigations.
South Korea 🇰🇷
Biopharma Research SupportSouth Korea expands deployment of small animal imaging systems alongside growing biopharmaceutical and life science research activities. Institutions seek integrated imaging technologies that accelerate preclinical validation while improving research productivity.
United States 🇺🇸
Translational Research HubThe U.S. continues expanding small animal imaging (in-vivo) capabilities across pharmaceutical research, biotechnology, and academic institutions. Investment focuses on multimodal imaging platforms that improve preclinical study efficiency and translational research outcomes.
Segment Leadership and Growth Trends
Small Animal Imaging (In-vivo) Market Share (%), by Modality, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportModality Segment Analysis: Optical Imaging Systems (Largest Segment) vs Micro-magnetic Resonance Imaging (Fastest-Growing Segment)
Optical imaging systems held the largest share of the small animal imaging (in-vivo) market, accounting for 40.81% in 2026. Their strong position is supported by widespread use in preclinical research, where researchers require sensitive, non-invasive visualization of biological processes in living animals. Optical systems offer advantages such as real-time imaging, relatively straightforward operation, and suitability for fluorescence- and bioluminescence-based studies, making them valuable for monitoring disease progression, evaluating therapeutic responses, and conducting longitudinal research.
Micro-magnetic resonance imaging is advancing rapidly as researchers place greater emphasis on high-resolution anatomical and functional assessment in preclinical models. Its ability to provide detailed soft-tissue visualization without ionizing radiation supports applications where precise structural information is essential, including neurological, cardiovascular, and tumor research. Increasing demand for sophisticated imaging techniques that can complement molecular imaging and deliver deeper biological insights is strengthening adoption of this modality.
Application Segment Analysis: Biodistribution Studies (Largest Segment) vs Cell Detection (Fastest-Growing Segment)
Biodistribution studies dominated the small animal imaging (in-vivo) market by application, representing 35.83% in 2026. These studies are integral to preclinical drug and therapeutic development because they help researchers determine how candidate compounds, biological agents, or delivery systems are distributed throughout the body. The growing emphasis on understanding tissue targeting, therapeutic exposure, and safety profiles is sustaining demand for in-vivo imaging tools capable of tracking biological agents across different organs and tissues.
Cell detection is gaining momentum as preclinical research increasingly focuses on monitoring cellular behavior, migration, proliferation, and therapeutic response. Advanced imaging capabilities enable researchers to observe labeled or engineered cells within living models while reducing the need for invasive procedures. The expanding development of cell-based therapies, regenerative approaches, and targeted treatments is creating greater demand for sensitive imaging methods that can provide actionable information on cellular activity and treatment performance.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Modality | Optical Imaging Systems, Micro-magnetic Resonance Imaging, Nuclear Imaging, Others | Optical Imaging Systems | Micro-magnetic Resonance Imaging |
| Application | Monitoring Drug Treatment Response, Biodistribution Studies, Cancer, Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics | Biodistribution Studies | Cell Detection |
Competitive Landscape and Market Positioning
Key companies in the small animal imaging (in-vivo) market:
1. PerkinElmer Inc. (United States)
2. Bruker Corporation (United States)
3. Siemens Healthineers AG (Germany)
4. FUJIFILM Holdings Corporation (Japan)
5. Thermo Fisher Scientific Inc. (United States)
6. Miltenyi Biotec B.V. & Co. KG (Germany)
7. Aspect Imaging Ltd. (Israel)
8. Mediso Ltd. (Hungary)
9. Promega Corporation (United States)
10. Revvity Inc. (United States)
The small animal imaging market is advancing with improved imaging resolution and enhanced biological analysis capabilities. Innovation in imaging modalities is strengthening research accuracy in preclinical studies. New system enhancements are enabling more detailed and non-invasive observation techniques. The small animal imaging market continues to evolve through precision-driven biomedical research advancements.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| PerkinElmer Inc. (United States) | |||||||
| Bruker Corporation (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| FUJIFILM Holdings Corporation (Japan) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Miltenyi Biotec B.V. & Co. KG (Germany) | |||||||
| Aspect Imaging Ltd. (Israel) | |||||||
| Mediso Ltd. (Hungary) | |||||||
| Promega Corporation (United States) | |||||||
| Revvity Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Small Animal Imaging (In-vivo) Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Animal Model Type | Rodents, Rabbits, Other Small Animal Models |
| Research Institution Type | Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Government & Public Research Laboratories |
| Procurement Model | Direct Equipment Purchase, Distributor-Mediated Purchase, Equipment Leasing/Rental, Imaging-as-a-Service |
Small Animal Imaging (In-vivo) Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Preclinical Research Investment Outlook |
|
| Drug Discovery Imaging Adoption Trends |
|
| Translational Research Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of small animal imaging (in-vivo)?
What are the growth projections for the small animal imaging industry?
How is expanding preclinical drug development influencing the use of in-vivo small animal imaging systems?
What role do imaging technology advancements and rising R&D investment play in driving adoption of small animal imaging systems?
Why do Optical Imaging Systems hold the largest share of the small animal imaging (in-vivo) market?
Why is Cell Detection the fastest-growing application in the small animal imaging (in-vivo) market?
Why does North America dominate the small animal imaging (in-vivo) market?
What is fueling growth in the Asia Pacific small animal imaging (in-vivo) market?
Which companies dominate the small animal imaging landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization